Start with a free account for 3 free CME credits. Already a subscriber? Sign in.

HIV Pre-Exposure Prophylaxis

Amy Stulman, AGNP-BC, Jess Pinder, AGNP-BP, and Spencer Blackman, MD
00:00
22:10
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

When taken daily, pre-exposure prophylaxis for HIV can prevent up to 99% of HIV infections in high risk individuals. Truvada, which consists of emtricitabine and tenofovir, is generally well tolerated, with rare incidence of GI side effects and renal impairment. Remember to screen for other STIs in these high risk patients as well as to check for HIV every three months as adherence may not be perfect.

 

To view chapter written summaries, you need to subscribe.

Sign up today for full access to all episodes.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
Jingle, Jingle Full episode audio for MD edition 178:44 min - 84 MB - M4AHippo Primary Care RAP - December 2017 Summary 310 KB - PDF